PureTech Health Announces PDMR Notification of RSU Vesting
Why we think this is neutral
This RNS announcement does not contain any of the mandatory news types specified, such as contract news, order news, trading update, financing, funding, annual results, asset sale/disposal, flow testing, licence news, or delisting. Therefore, the sentiment is assessed as neutral.
Key Points
- Restricted share units granted to certain directors and other PDMRs have vested
- PDMRs received vested ordinary shares after deduction of shares for payroll taxes
Summary
The biotechnology company has announced the vesting of restricted share units for certain directors and other persons discharging managerial responsibilities.
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) has announced that awards of restricted share units ("RSUs") granted to certain directors and other persons discharging managerial responsibilities ("PDMRs") pursuant to its Performance Share Plan have vested. The PDMRs received vested ordinary shares (after deduction of shares for payroll taxes) on 07 July 2025.
DIRECTOR DEALINGS